Huons recalls two lots of heparin sodium injection

Published: 2008-03-21 06:56:00

Updated: 2008-03-21 06:56:00

Huons Corporation is performing a voluntary recall two lots of heparin sodium injections due to incomplete removal of impurities sourced from a Chinese supplier, Yantai Hepu Biological Product Co., the Korea Food and Drug Administration said on March 18.

The full Huons product recall now compr...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK